How to Buy amrutanjan Shares on Fincept?
You can buy Amrutanjan Health Care Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Amrutanjan Health Care Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Amrutanjan, including updates on board meetings and corporate actions.
Amrutanjan Health Care Limited - https://www.amrutanjan.com
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products comprising pain balms and roll-ons; and back pain roll-ons, stick-on patch, body pain gels, and joint muscle sprays. The company offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints. It also provides sanitary napkins for women. In addition, the company offers corn caps; dental gel; hand sanitizers; and juice drinks under the Fruitnik and Fruitnik Electro+ brand names, as well as operates a pain management center. It exports its products to the Middle East, Africa, Southeast Asia, and internationally. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
Amrutanjan Health Care Limited Share Price Today
677.30
OPEN
680.00
HIGH
664.00
LOW
666.00
CLOSE
8 K
VOLUME
2,129 Cr
Market Cap
52183
Average Volume
Healthcare
Sector
NSI
Exchange
Amrutanjan Health Care Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: AMRUTANJAN Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Amrutanjan Health Care Limited |
AMRUTANJAN |
INE098F01015 |
Interim Dividend - Re 1 Per Share |
22 Nov 2024 |
1 |
N/A |
Amrutanjan Health Care Limited |
AMRUTANJAN |
INE098F01015 |
Annual General Meeting |
13 Sep 2024 |
1 |
N/A |
Amrutanjan Health Care Limited |
AMRUTANJAN |
INE098F01015 |
Dividend - Rs 2.60 Per Share |
13 Sep 2024 |
1 |
N/A |
Amrutanjan Health Care Limited |
AMRUTANJAN |
INE098F01015 |
Interim Dividend - Re 1 Per Share |
20 Feb 2024 |
1 |
N/A |
Amrutanjan Health Care Limited |
AMRUTANJAN |
INE098F01015 |
Interim Dividend - Rs 1 Per Share |
23 Nov 2023 |
1 |
N/A |
NSE: AMRUTANJAN Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
AMRUTANJAN |
26 Dec 2024, 15:59:11 |
Trading Window-XBRL |
Pharmaceuticals |
AMRUTANJAN |
26 Dec 2024, 15:46:38 |
Trading Window |
Pharmaceuticals |
AMRUTANJAN |
13 Dec 2024, 12:38:43 |
Loss/Duplicate-Share Certificate-XBRL |
Pharmaceuticals |
AMRUTANJAN |
13 Dec 2024, 12:06:49 |
Loss of Share Certificates |
Pharmaceuticals |
AMRUTANJAN |
14 Nov 2024, 17:41:07 |
Revised Record date |
Pharmaceuticals |
NSE: AMRUTANJAN Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Amrutanjan Health Care Limited |
AMRUTANJAN |
18 Oct 2024, 16:15:00 |
18 Oct 2024, 16:15:00 |
|
Amrutanjan Health Care Limited |
AMRUTANJAN |
15 Jul 2024, 16:45:00 |
15 Jul 2024, 16:45:00 |
|
Amrutanjan Health Care Limited |
AMRUTANJAN |
17 Apr 2024, 11:06:00 |
17 Apr 2024, 11:30:00 |
|
Amrutanjan Health Care Limited |
AMRUTANJAN |
19 Jan 2024, 10:45:00 |
19 Jan 2024, 11:15:00 |
|
Amrutanjan Health Care Limited |
AMRUTANJAN |
19 Oct 2023, 14:45:00 |
19 Oct 2023, 15:15:00 |
NSE: AMRUTANJAN Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director-CEO-MD |
10 Jun 1974 |
01 Apr 2009 |
00015729 |
SAMBHUPRASAD SIVALENKA |
Active |
Non-Executive Director |
01 Mar 1957 |
21 Sep 2023 |
00820000 |
GOVINDAN RAGHAVAN |
Active |
Independent Director |
08 Dec 1956 |
27 May 2021 |
00669376 |
RAJA VENKATARAMAN |
Active |
Independent Director |
19 Nov 1956 |
29 Jun 2021 |
09198315 |
S MURALIDHARAN |
Active |
Independent Director |
27 Jun 1960 |
12 Aug 2022 |
07145001 |
MEENA LOCHANI RAGHUNATHAN |
Active |
NSE: AMRUTANJAN Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
AMRUTANJAN |
N/A |
INE098F01015 |
Amrutanjan Health Care Limited |
04 Nov 2024, 17:31:02 |
Financial Results |
AMRUTANJAN |
N/A |
INE098F01015 |
Amrutanjan Health Care Limited |
05 Aug 2024, 14:55:36 |
AMRUTANJAN HEALTH CARE LIMITED has informed the Exchange about Board Meeting to be held on 23-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
AMRUTANJAN |
N/A |
INE098F01015 |
Amrutanjan Health Care Limited |
14 May 2024, 18:13:17 |
AMRUTANJAN HEALTH CARE LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Dividend. |
AMRUTANJAN |
N/A |
INE098F01015 |
Amrutanjan Health Care Limited |
01 Feb 2024, 20:11:03 |
AMRUTANJAN HEALTH CARE LIMITED has informed the Exchange about Board Meeting to be held on 10-Nov-2023 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2023 and Dividend. |
AMRUTANJAN |
N/A |
INE098F01015 |
Amrutanjan Health Care Limited |
02 Nov 2023, 17:59:02 |
NSE: AMRUTANJAN Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results/Dividend |
AMRUTANJAN |
- |
INE098F01015 |
Amrutanjan Health Care Limited |
04 Nov 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 and dividend |
Financial Results |
AMRUTANJAN |
- |
INE098F01015 |
Amrutanjan Health Care Limited |
05 Aug 2024, 00:00:00 |
To consider and approve the Un-Audited financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
AMRUTANJAN |
- |
INE098F01015 |
Amrutanjan Health Care Limited |
14 May 2024, 00:00:00 |
To consider and approve the audited financial results for the period ended March 31, 2024 and recommendation of final dividend |
Financial Results/Dividend |
AMRUTANJAN |
- |
INE098F01015 |
Amrutanjan Health Care Limited |
01 Feb 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 and dividend |
Financial Results/Dividend |
AMRUTANJAN |
- |
INE098F01015 |
Amrutanjan Health Care Limited |
02 Nov 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 and Declaration of 1st Interim Dividend for the financial year 2023-24. |
NSE: AMRUTANJAN Balance Sheet Data In (Cr)
| date | period_type | Treasury Shares Number | Ordinary Shares Number | Share Issued | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Treasury Stock | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Non Current Deferred Revenue | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Goodwill And Other Intangible Assets | Other Intangible Assets | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Raw Materials | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 12,527.00 | 28,898,103.00 | 28,910,630.00 | 22,142,000.00 | 2,956,890,000.00 | 2,977,882,000.00 | 2,302,027,000.00 | 2,956,890,000.00 | 22,142,000.00 | 2,977,882,000.00 | 2,977,882,000.00 | 2,977,882,000.00 | 2,977,882,000.00 | 2,948,971,000.00 | 0.00 | 0.00 | 0.00 | 28,911,000.00 | 28,911,000.00 | 848,068,000.00 | 94,105,000.00 | 0.00 | 17,964,000.00 | 17,964,000.00 | 74,291,000.00 | 753,963,000.00 | 93,031,000.00 | 4,178,000.00 | 4,178,000.00 | 21,936,000.00 | 549,722,000.00 | 0.00 | 0.00 | 16,220,000.00 | 533,502,000.00 | 3,825,950,000.00 | 769,960,000.00 | 34,484,000.00 | 0.00 | 33,072,000.00 | 141,441,000.00 | 141,441,000.00 | 0.00 | 20,992,000.00 | 20,992,000.00 | 491,380,000.00 | 0.00 | 491,380,000.00 | 6,601,000.00 | 484,779,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,055,990,000.00 | 89,609,000.00 | 0.00 | 0.00 | 326,327,000.00 | 0.00 | 0.00 | 0.00 | 346,341,000.00 | 0.00 | 0.00 | 2,293,713,000.00 | 2,222,979,000.00 | 70,734,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | annual | 19,672.00 | 28,890,958.00 | 28,910,630.00 | 17,283,000.00 | 2,861,101,000.00 | 2,884,883,000.00 | 2,257,634,000.00 | 2,861,101,000.00 | 17,283,000.00 | 2,884,883,000.00 | 2,884,883,000.00 | 2,884,883,000.00 | 2,884,883,000.00 | -4,016,000.00 | 16,175,000.00 | 2,362,131,000.00 | 3,089,000.00 | 28,911,000.00 | 28,911,000.00 | 783,824,000.00 | 84,639,000.00 | 10,000.00 | 13,968,000.00 | 13,968,000.00 | 69,011,000.00 | 699,185,000.00 | 84,034,000.00 | 3,315,000.00 | 3,315,000.00 | 20,287,000.00 | 665,019,000.00 | 81,733,000.00 | 8,440,000.00 | 16,220,000.00 | 558,626,000.00 | 3,668,707,000.00 | 711,888,000.00 | 17,139,000.00 | 17,139,000.00 | 31,719,000.00 | 117,805,000.00 | 117,374,000.00 | 431,000.00 | 23,782,000.00 | 23,782,000.00 | 495,436,000.00 | -234,945,000.00 | 730,381,000.00 | 23,445,000.00 | 27,239,000.00 | 413,931,000.00 | 243,614,000.00 | 22,152,000.00 | 0.00 | 2,956,819,000.00 | 75,731,000.00 | 8,439,000.00 | 75,732,000.00 | 289,047,000.00 | 63,115,000.00 | 152,952,000.00 | 72,980,000.00 | 478,894,000.00 | -82,022,000.00 | 560,916,000.00 | 2,104,707,000.00 | 1,847,072,000.00 | 257,635,000.00 | 220,515,000.00 | 37,120,000.00 |
| 2024-03-31T00:00:00 | quarterly | 19,672.00 | 28,890,958.00 | 28,910,630.00 | 17,283,000.00 | 2,861,101,000.00 | 2,884,883,000.00 | 2,257,634,000.00 | 2,861,101,000.00 | 17,283,000.00 | 2,884,883,000.00 | 2,884,883,000.00 | 2,884,883,000.00 | 2,884,883,000.00 | -4,016,000.00 | 16,175,000.00 | 2,362,131,000.00 | 3,089,000.00 | 28,911,000.00 | 28,911,000.00 | 783,824,000.00 | 84,639,000.00 | 10,000.00 | 13,968,000.00 | 13,968,000.00 | 69,011,000.00 | 699,185,000.00 | 84,034,000.00 | 3,315,000.00 | 3,315,000.00 | 20,287,000.00 | 665,019,000.00 | 81,733,000.00 | 8,440,000.00 | 16,220,000.00 | 558,626,000.00 | 3,668,707,000.00 | 711,888,000.00 | 17,139,000.00 | 17,139,000.00 | 31,719,000.00 | 117,805,000.00 | 117,374,000.00 | 431,000.00 | 23,782,000.00 | 23,782,000.00 | 495,436,000.00 | -234,945,000.00 | 730,381,000.00 | 23,445,000.00 | 27,239,000.00 | 413,931,000.00 | 243,614,000.00 | 22,152,000.00 | 0.00 | 2,956,819,000.00 | 75,731,000.00 | 8,439,000.00 | 75,732,000.00 | 289,047,000.00 | 63,115,000.00 | 152,952,000.00 | 72,980,000.00 | 478,894,000.00 | -82,022,000.00 | 560,916,000.00 | 2,104,707,000.00 | 1,847,072,000.00 | 257,635,000.00 | 220,515,000.00 | 37,120,000.00 |
| 2023-09-30T00:00:00 | quarterly | 52,232.00 | 28,858,398.00 | 28,910,630.00 | 6,659,000.00 | 2,598,930,000.00 | 2,620,030,000.00 | 1,898,478,000.00 | 2,598,930,000.00 | 6,659,000.00 | 2,620,030,000.00 | 2,620,030,000.00 | 2,620,030,000.00 | 2,620,030,000.00 | 2,591,119,000.00 | 0.00 | 0.00 | 0.00 | 28,911,000.00 | 28,911,000.00 | 930,511,000.00 | 76,028,000.00 | 0.00 | 3,710,000.00 | 3,710,000.00 | 70,658,000.00 | 854,483,000.00 | 135,767,000.00 | 2,949,000.00 | 2,949,000.00 | 27,778,000.00 | 602,426,000.00 | 0.00 | 0.00 | 0.00 | 602,426,000.00 | 3,550,541,000.00 | 797,580,000.00 | 20,882,000.00 | 0.00 | 40,477,000.00 | 177,017,000.00 | 177,017,000.00 | 0.00 | 21,100,000.00 | 0.00 | 479,524,000.00 | 0.00 | 479,524,000.00 | 2,065,000.00 | 477,459,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,752,961,000.00 | 60,429,000.00 | 0.00 | 0.00 | 308,903,000.00 | 0.00 | 0.00 | 0.00 | 334,890,000.00 | 0.00 | 0.00 | 2,048,739,000.00 | 1,956,143,000.00 | 92,596,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | annual | 52,232.00 | 29,178,398.00 | 29,230,630.00 | 9,091,000.00 | 2,882,880,000.00 | 2,907,719,000.00 | 1,969,354,000.00 | 2,882,880,000.00 | 9,091,000.00 | 2,907,719,000.00 | 2,907,719,000.00 | 2,907,719,000.00 | 2,907,719,000.00 | 10,441,000.00 | 44,571,000.00 | 2,398,906,000.00 | 2,769,000.00 | 29,231,000.00 | 29,231,000.00 | 713,214,000.00 | 83,093,000.00 | 10,000.00 | 4,040,000.00 | 4,040,000.00 | 77,393,000.00 | 630,121,000.00 | 78,505,000.00 | 5,051,000.00 | 5,051,000.00 | 19,273,000.00 | 596,762,000.00 | 80,552,000.00 | 9,314,000.00 | 32,535,000.00 | 474,361,000.00 | 3,620,933,000.00 | 1,021,458,000.00 | 15,357,000.00 | 15,012,000.00 | 42,544,000.00 | 426,501,000.00 | 426,270,000.00 | 231,000.00 | 24,839,000.00 | 24,839,000.00 | 475,454,000.00 | -227,658,000.00 | 703,112,000.00 | 11,144,000.00 | 23,956,000.00 | 415,763,000.00 | 229,082,000.00 | 23,167,000.00 | 0.00 | 2,599,475,000.00 | 51,364,000.00 | 27,553,000.00 | 55,453,000.00 | 288,251,000.00 | 46,054,000.00 | 174,499,000.00 | 67,698,000.00 | 330,203,000.00 | -61,317,000.00 | 391,520,000.00 | 1,898,015,000.00 | 1,222,409,000.00 | 675,606,000.00 | 626,578,000.00 | 49,028,000.00 |
| 2023-03-31T00:00:00 | quarterly | 52,232.00 | 29,178,398.00 | 29,230,630.00 | 9,091,000.00 | 2,882,880,000.00 | 2,907,719,000.00 | 1,969,354,000.00 | 2,882,880,000.00 | 9,091,000.00 | 2,907,719,000.00 | 2,907,719,000.00 | 2,907,719,000.00 | 2,907,719,000.00 | 10,441,000.00 | 44,571,000.00 | 2,398,906,000.00 | 2,769,000.00 | 29,231,000.00 | 29,231,000.00 | 713,214,000.00 | 83,093,000.00 | 10,000.00 | 4,040,000.00 | 4,040,000.00 | 77,393,000.00 | 630,121,000.00 | 78,505,000.00 | 5,051,000.00 | 5,051,000.00 | 19,273,000.00 | 596,762,000.00 | 80,552,000.00 | 9,314,000.00 | 32,535,000.00 | 474,361,000.00 | 3,620,933,000.00 | 1,021,458,000.00 | 15,357,000.00 | 15,012,000.00 | 42,544,000.00 | 426,501,000.00 | 426,270,000.00 | 231,000.00 | 24,839,000.00 | 24,839,000.00 | 475,454,000.00 | -227,658,000.00 | 703,112,000.00 | 11,144,000.00 | 23,956,000.00 | 415,763,000.00 | 229,082,000.00 | 23,167,000.00 | 0.00 | 2,599,475,000.00 | 51,364,000.00 | 27,553,000.00 | 55,453,000.00 | 288,251,000.00 | 46,054,000.00 | 174,499,000.00 | 67,698,000.00 | 330,203,000.00 | -61,317,000.00 | 391,520,000.00 | 1,898,015,000.00 | 1,222,409,000.00 | 675,606,000.00 | 626,578,000.00 | 49,028,000.00 |
| 2022-03-31T00:00:00 | annual | 53,011.00 | 29,177,619.00 | 29,230,630.00 | 8,799,000.00 | 2,628,051,000.00 | 2,651,238,000.00 | 1,971,763,000.00 | 2,628,051,000.00 | 8,799,000.00 | 2,651,238,000.00 | 2,651,238,000.00 | 2,651,238,000.00 | 2,651,238,000.00 | 6,065,000.00 | 44,980,000.00 | 2,147,210,000.00 | 2,769,000.00 | 29,231,000.00 | 29,231,000.00 | 847,443,000.00 | 72,713,000.00 | 0.00 | 3,106,000.00 | 3,106,000.00 | 67,947,000.00 | 774,730,000.00 | 65,012,000.00 | 5,693,000.00 | 5,693,000.00 | 42,431,000.00 | 704,244,000.00 | 80,813,000.00 | 18,943,000.00 | 0.00 | 604,488,000.00 | 3,498,681,000.00 | 752,188,000.00 | 19,228,000.00 | 18,471,000.00 | 36,419,000.00 | 223,094,000.00 | 169,497,000.00 | 53,597,000.00 | 23,187,000.00 | 23,187,000.00 | 434,704,000.00 | -187,631,000.00 | 622,335,000.00 | 162,649,000.00 | 17,698,000.00 | 233,107,000.00 | 185,714,000.00 | 23,167,000.00 | 0.00 | 2,746,493,000.00 | 50,460,000.00 | 42,679,000.00 | 50,460,000.00 | 260,007,000.00 | 45,376,000.00 | 157,225,000.00 | 57,406,000.00 | 382,560,000.00 | -63,530,000.00 | 446,090,000.00 | 2,010,787,000.00 | 1,175,940,000.00 | 834,847,000.00 | 812,985,000.00 | 21,862,000.00 |
| 2021-03-31T00:00:00 | annual | 0.00 | 29,230,630.00 | 29,230,630.00 | 13,424,000.00 | 2,140,503,000.00 | 2,155,647,000.00 | 1,707,950,000.00 | 2,140,503,000.00 | 13,424,000.00 | 2,155,647,000.00 | 2,155,647,000.00 | 2,155,647,000.00 | 2,155,647,000.00 | 6,178,000.00 | 9,641,000.00 | 1,616,167,000.00 | 2,769,000.00 | 29,231,000.00 | 29,231,000.00 | 587,060,000.00 | 66,026,000.00 | 0.00 | 7,028,000.00 | 7,028,000.00 | 57,238,000.00 | 521,034,000.00 | 48,600,000.00 | 6,396,000.00 | 6,396,000.00 | 34,885,000.00 | 463,833,000.00 | 47,900,000.00 | 9,246,000.00 | 0.00 | 406,687,000.00 | 2,742,707,000.00 | 513,723,000.00 | -100,000.00 | 11,032,000.00 | 34,250,000.00 | 205,974,000.00 | 85,853,000.00 | 120,121,000.00 | 15,144,000.00 | 15,144,000.00 | 233,170,000.00 | -155,546,000.00 | 388,716,000.00 | 4,139,000.00 | 7,374,000.00 | 189,049,000.00 | 164,987,000.00 | 23,167,000.00 | 0.00 | 2,228,984,000.00 | 38,221,000.00 | 86,194,000.00 | 38,221,000.00 | 174,586,000.00 | 35,855,000.00 | 102,226,000.00 | 36,505,000.00 | 176,629,000.00 | -79,855,000.00 | 256,484,000.00 | 1,753,354,000.00 | 446,378,000.00 | 1,306,976,000.00 | 1,277,925,000.00 | 29,051,000.00 |
NSE: AMRUTANJAN Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repurchase Of Capital Stock | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Payments | Common Stock Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 211,929,000.00 | -288,000,000.00 | 11,789,000.00 | -67,177,000.00 | 37,120,000.00 | 49,028,000.00 | 0.00 | -11,908,000.00 | -482,664,000.00 | -67,018,000.00 | 0.00 | -133,863,000.00 | 0.00 | -276,211,000.00 | -288,000,000.00 | 11,789,000.00 | 191,650,000.00 | 0.00 | 141,203,000.00 | 115,038,000.00 | 115,038,000.00 | 0.00 | -64,591,000.00 | 2,586,000.00 | -67,177,000.00 | 0.00 | 279,106,000.00 | -164,971,000.00 | -101,880,000.00 | 2,199,000.00 | -23,654,000.00 | 95,409,000.00 | -796,000.00 | -169,681,000.00 | -146,871,000.00 | 2,150,000.00 | 9,561,000.00 | 60,569,000.00 | 8,491,000.00 | 52,078,000.00 | 1,264,000.00 | 0.00 | -1,571,000.00 | 619,460,000.00 |
| 2023-03-31T00:00:00 | annual | 112,543,000.00 | 0.00 | 0.00 | -89,267,000.00 | 49,028,000.00 | 21,862,000.00 | 0.00 | 27,166,000.00 | -149,894,000.00 | 0.00 | 0.00 | -144,091,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -24,750,000.00 | 0.00 | 112,327,000.00 | -48,246,000.00 | 75,002,000.00 | -123,248,000.00 | -88,831,000.00 | 436,000.00 | -89,267,000.00 | 0.00 | 201,810,000.00 | -160,626,000.00 | -96,404,000.00 | -13,296,000.00 | 2,236,000.00 | -106,667,000.00 | -28,244,000.00 | 47,722,000.00 | -117,059,000.00 | 4,376,000.00 | -19,460,000.00 | 52,115,000.00 | 7,939,000.00 | 44,176,000.00 | 2,048,000.00 | 0.00 | -269,000.00 | 536,454,000.00 |
| 2022-03-31T00:00:00 | annual | 287,322,000.00 | 0.00 | -35,339,000.00 | -234,634,000.00 | 21,862,000.00 | 29,051,000.00 | -2,000.00 | -7,187,000.00 | -167,024,000.00 | 0.00 | 0.00 | -124,765,000.00 | 0.00 | -35,339,000.00 | 0.00 | -35,339,000.00 | -362,119,000.00 | 0.00 | 126,338,000.00 | -253,823,000.00 | 48,237,000.00 | -302,060,000.00 | -234,634,000.00 | 0.00 | -234,634,000.00 | 0.00 | 521,956,000.00 | -241,920,000.00 | -39,285,000.00 | 20,095,000.00 | -12,633,000.00 | 236,789,000.00 | -85,421,000.00 | -209,918,000.00 | -106,854,000.00 | -113,000.00 | -35,001,000.00 | 37,952,000.00 | 1,393,000.00 | 36,559,000.00 | 1,411,000.00 | 0.00 | 0.00 | 905,766,000.00 |
| 2021-03-31T00:00:00 | annual | 889,085,000.00 | -9,641,000.00 | -9,641,000.00 | -19,607,000.00 | 29,051,000.00 | 72,206,000.00 | -9,000.00 | -43,146,000.00 | -74,230,000.00 | -9,641,000.00 | -333,000.00 | -57,833,000.00 | 0.00 | -9,641,000.00 | -9,641,000.00 | -9,641,000.00 | -877,608,000.00 | 0.00 | 56,378,000.00 | -915,273,000.00 | 0.00 | -915,273,000.00 | -18,713,000.00 | 894,000.00 | -19,607,000.00 | 0.00 | 908,692,000.00 | -186,965,000.00 | 306,124,000.00 | 41,875,000.00 | 32,593,000.00 | 94,990,000.00 | 62,573,000.00 | 72,554,000.00 | -88,884,000.00 | 6,178,000.00 | 14,249,000.00 | 36,697,000.00 | 1,659,000.00 | 35,038,000.00 | 3,666,000.00 | -524,000.00 | -894,000.00 | 819,045,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -18,927,000.00 | -260,000.00 | 0.00 | -92,076,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,000.00 | 0.00 | 0.00 | 0.00 | -217,069,000.00 | 0.00 | 0.00 | 0.00 | -25,444,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -355,000.00 | 0.00 | 0.00 |
NSE: AMRUTANJAN Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Discontinuous Operations | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Impairment Of Capital Assets | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -0.21 | 0.00 | 68.92 | -0.76 | -0.76 | 44.97 | 6.06 | 211.83 | 68.16 | 62.10 | 14.55 | 0.16 | 14.80 | 45.52 | 44.97 | 372.10 | 0.71 | 2.90 | 2.90 | 0.00 | 0.00 | 44.97 | 44.97 | 0.00 | 44.97 | 44.97 | 0.00 | 44.97 | 16.97 | 61.95 | 0.07 | -0.63 | -0.16 | 0.68 | 0.11 | 14.55 | 0.09 | 0.16 | 14.80 | 48.02 | 160.28 | 22.26 | 6.06 | 0.85 | 5.21 | 78.69 | 73.49 | 5.20 | 0.71 | 208.29 | 211.83 | 420.12 | 420.12 |
| 2023-03-31T00:00:00 | annual | -0.06 | 0.00 | 59.18 | -0.24 | -0.24 | 39.83 | 5.21 | 181.98 | 58.93 | 53.72 | 11.56 | 0.08 | 11.78 | 40.01 | 39.83 | 336.16 | 0.41 | 2.92 | 2.92 | 0.00 | 0.00 | 39.83 | 39.83 | 0.00 | 39.83 | 39.83 | 0.00 | 39.83 | 13.81 | 53.65 | 0.02 | -0.04 | -0.03 | 0.06 | 0.00 | 11.56 | 0.15 | 0.08 | 11.78 | 42.06 | 154.18 | 18.58 | 5.21 | 0.79 | 4.42 | 77.17 | 72.71 | 4.46 | 0.41 | 196.25 | 181.98 | 378.23 | 378.23 |
| 2022-03-31T00:00:00 | annual | -0.56 | 0.00 | 97.03 | -2.18 | -2.18 | 67.19 | 3.80 | 180.46 | 94.86 | 91.06 | 10.59 | 0.48 | 11.17 | 68.80 | 67.19 | 322.57 | 0.25 | 2.92 | 2.92 | 0.00 | 0.00 | 67.19 | 67.19 | 0.00 | 67.19 | 67.19 | 0.00 | 67.19 | 23.39 | 90.58 | 0.07 | -2.04 | 0.00 | 2.04 | 0.00 | 10.59 | 0.10 | 0.48 | 11.17 | 81.97 | 142.11 | 9.66 | 3.80 | 0.14 | 3.66 | 75.66 | 72.94 | 2.73 | 0.25 | 224.08 | 180.46 | 404.55 | 404.55 |
| 2021-03-31T00:00:00 | annual | -2.00 | 0.00 | 93.97 | -7.89 | -7.89 | 61.19 | 3.67 | 140.19 | 86.07 | 82.40 | 8.80 | 0.50 | 9.39 | 67.09 | 61.19 | 253.03 | 0.35 | 2.92 | 2.92 | 0.00 | 0.00 | 61.19 | 61.19 | 0.00 | 61.19 | 61.19 | 0.00 | 61.19 | 20.71 | 81.90 | 1.44 | -7.53 | -0.09 | 7.62 | 0.00 | 8.80 | 0.09 | 0.50 | 9.39 | 79.50 | 112.85 | 5.20 | 3.67 | 0.17 | 3.50 | 58.03 | 55.59 | 2.44 | 0.35 | 192.35 | 140.19 | 332.53 | 332.53 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
16.41
P/E
44.83547
P/B
7.3732786
Dividend Yield
1.08%
Market Cap
2,128.87 Cr.
Face Value
99.786
Book Value
99.786
ROE
9.97%
EBITDA Growth
48.52 Cr.
Debt/Equity
0.599
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of amrutanjan?
The market capitalization of Amrutanjan Health Care Limited is ₹2,129 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Amrutanjan Health Care Limited?
The PE and PB ratios of Amrutanjan Health Care Limited are Not Available and 7.3732786 respectively as of 05 Feb 2025.
What is the 52 Week High of Amrutanjan Health Care Limited?
The 52-week high of Amrutanjan Health Care Limited is ₹862.6 as of 05 Feb 2025.
What is the 52 Week Low of Amrutanjan Health Care Limited?
The 52-week low of Amrutanjan Health Care Limited is ₹570 as of 05 Feb 2025.
What are the earnings per share (EPS) for Amrutanjan Health Care Limited?
The Earnings Per Share (EPS) of Amrutanjan Health Care Limited is ₹16.41 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Amrutanjan Health Care Limited?
The Return on Equity (ROE) of Amrutanjan Health Care Limited is 9.97% as per the most recent financial year data. Explore more on Fincept.